Inter- and intramouse heterogeneity of radiation response for a growing paired organ

Radiation Research

Volumn 170, Issue 2, 2008, Pages 264-267

  Kozin, Sergey V ^a   Niemierko, Andrzej ^a   Huang, Peigen ^a   Silva, Jose ^a   Doppke, Karen P ^a   Suit, Herman D ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EPIGENETICS; FEMALE; GAMMA IRRADIATION; GENETIC HETEROGENEITY; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE; RADIATION EXPOSURE; RADIOSENSITIVITY; STOCHASTIC MODEL;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, RADIATION; MICE; MICE, INBRED C3H; RADIATION DOSAGE; SENSITIVITY AND SPECIFICITY; TIBIA;

MUS; RODENTIA;

EID: 49249112411     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/RR1262.1     Document Type: Article

References (17)

1. N. S. Russell and A. C. Begg, Predictive assays for normal tissue damage. Radiother. Oncol. 64, 125-129 (2002).
2. S. L. Tucker, I. Turesson and H. D. Thames, Evidence for individual differences in the radiosensitivity of human skin. Eur. J. Cancer 28A, 1783-1791 (1992).
3. S. M. Bentzen, M. Overgaard and J. Overgaard, Clinical correlations between late normal tissue endpoints after radiotherapy: implications for predictive assays of radiosensitivity. Eur. J. Cancer 29A, 1373-1376 (1993).
4. A. Safwat, S. M. Bentzen, I. Turesson and J. H. Hendry, Deterministic rather than stochastic factors explain most of the variation in the expression of skin telangiectasia after radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 52, 198-204 (2002).
5. C. N. Andreassen, J. Alsner and J. Overgaard, Does variability in normal tissue reactions after radiotherapy have a genetic basis - where and how to look for it? Radiother. Oncol. 64, 131-140 (2002).
6. C. N. Andreassen, Can risk of radiotherapy-induced normal tissue complications be predicted from genetic profiles? Acta Oncol. 44, 801-815 (2005).
7. S. M. Bentzen, Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology. Nat. Rev. Cancer 6, 702-713 (2006).
8. M. Baumann, T. Holscher and A. C. Begg, Towards genetic prediction of radiation responses: ESTRO's GENEPI project. Radiother. Oncol. 69, 121-125 (2003).
9. O. K. Rodningen, J. Overgaard, J. Alsner, T. Hastie and A. L. Borresen-Dale, Microarray analysis of the transcriptional response to single or multiple doses of ionizing radiation in human subcutaneous fibroblasts. Radiother. Oncol. 77, 231-240 (2005).
10. R. L. Jirtle and M. K. Skinner, Environmental epigenomics and disease susceptibility. Nat. Rev. Genet. 8, 253-262 (2007).
11. J. W. Denham, M. Hauer-Jensen, T. Kron and C. W. Langberg, Treatment-time-dependence models of early and delayed radiation injury in rat small intestine. Int. J. Radiat. Oncol. Biol. Phys. 48, 871-887 (2000).
12. S. V. Kozin, Y. Boucher, D. J. Hicklin, P. Bohlen, R. K. Jain and H. D. Suit, Vascular endothelial growth factor receptor-2-blocking antibody potentiates radiation-induced long-term control of human tumor xenografts. Cancer Res. 61, 39-44 (2001).
13. E. B. Hranitzky, P. R. Almond, H. D. Suit and E. B. Moore, A cesium-137 irradiator for small laboratory animals. Radiology 107, 641-644 (1973).
14. I. Turesson, Characteristics of dose-response relationships for late radiation effects: an analysis of skin telangiectasia and of head and neck morbidity. Radiother. Oncol. 20, 149-158 (1991).
15. H. Paganetti, A. Niemierko, M. Ancukiewicz, L. E. Gerweck, M. Goitein, J. S. Loeffler and H. D. Suit, Relative biological effectiveness (RBE) values for proton beam therapy. Int. J. Radiat. Oncol. Biol. Phys. 53, 407-421 (2002).
16. M. E. Philippens, L. A. Pop, A. G. Visser, S. A. Schellekens and A. J. van der Kogel, Dose-volume effects in rat thoracolumbar spinal cord: an evaluation of NTCP models. Int. J. Radiat. Oncol. Biol. Phys. 60, 578-590 (2004).
17. H. Suit, S. Skates, A. Taghian, P. Okunieff and J. T. Efird, Clinical implications of heterogeneity of tumor response to radiation therapy. Radiother. Oncol. 25, 251-260 (1992).